Webinars intro text title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Et malesuada fames ac turpis egestas integer eget. Ut sem viverra aliquet eget sit amet tellus cras. Fames ac turpis egestas sed tempus urna et. Massa sed elementum tempus egestas sed sed risus. Suspendisse ultrices gravida dictum fusce ut. Duis ultricies lacus sed turpis. Semper eget duis at tellus. Sed odio morbi quis commodo odio aenean. Nulla facilisi etiam dignissim diam quis enim. Ac felis donec et odio pellentesque diam. Quis varius quam quisque id diam vel quam elementum pulvinar. Id faucibus nisl tincidunt eget nullam non nisi est. Amet tellus cras adipiscing enim eu turpis.


OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.


OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure to phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This site is intended for US Physician educational purposes only, using scientific exchange around the OMIDRIA experience.

Rayner, the Rayner logo, OMIDRIA, the OMIDRIA logo, and OMIDRIAssure are proprietary marks of Rayner. ©2022 Rayner Group, all rights reserved.  US-OM-2200071 12/22